Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Mar. 31, 2024 |
Mar. 31, 2023 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Income Statement [Abstract] | ||||||
| Revenue | $ 31,866 | $ 16,654 | $ 77,733 | $ 22,914 | $ 75,724 | $ 15,652 |
| Operating expenses: | ||||||
| Cost of revenues | 21,555 | 18,718 | 45,161 | 36,353 | 78,163 | 51,489 |
| Selling, general and administrative expenses | 683,184 | 1,252,786 | 1,994,534 | 2,355,701 | 4,371,164 | 4,519,636 |
| Research and development expenses | 203,869 | 170,634 | 409,449 | 332,087 | 670,880 | 1,153,333 |
| Total operating expenses | 908,608 | 1,442,138 | 2,449,144 | 2,724,141 | 5,120,207 | 5,724,458 |
| Loss from operations | (876,742) | (1,425,484) | (2,371,411) | (2,701,227) | (5,044,483) | (5,708,806) |
| Other (expense) income: | ||||||
| Interest expense | (592,397) | (635,190) | (1,779,380) | (1,159,503) | (3,096,550) | (567,048) |
| Change in fair value of derivative liability | 1,158,197 | 1,000,000 | ||||
| Gain on extinguishment of derivative liabilities | 1,158,197 | 1,158,197 | ||||
| Total other (expense) income, net | (592,397) | 523,007 | (1,779,380) | (1,306) | (1,938,353) | 432,952 |
| Net loss | $ (1,469,139) | $ (902,477) | $ (4,150,791) | $ (2,702,533) | $ (6,982,836) | $ (5,275,854) |
| Loss per share - basic and diluted | ||||||
| Net loss per common share, basic | $ (0.33) | $ (0.71) | $ (0.90) | $ (2.15) | $ (2.27) | $ (4.40) |
| Net loss per common share, diluted | $ (0.33) | $ (0.71) | $ (0.90) | $ (2.15) | $ (2.27) | $ (4.40) |
| Weighted common shares, basic | 4,497,111 | 1,263,585 | 4,602,623 | 1,258,099 | 3,074,115 | 1,199,575 |
| Weighted common shares, diluted | 4,497,111 | 1,263,585 | 4,602,623 | 1,258,099 | 3,074,115 | 1,199,575 |
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|